Source: Annual Congress 2006 - Biological features, lung function and treatment of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. A. Huang, T. Z. Yan, Y. B. Zhu, Y. Huang, X. G. Zhang (Suzhou, China). Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer. Eur Respir J 2006; 28: Suppl. 50, 4437

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of dendritic cells in peripheral blood and pleural effusion of non-small-cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 529s Year: 2004 Evaluation of concomitant pleural effusions in patients with lung cancers Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007 Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020 Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Biochemical and cytological features of metastatic pleural effusions in breast cancer Source: Eur Respir J 2007; 30: Suppl. 51, 671s Year: 2007 Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Malignant pericardial effusion in lung cancer patients Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions Year: 2006 Mast cells recruitment to malignant pleural effusions Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Pleural effusions in lung cancer Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012 Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011 Survival of lung adenocarcinoma patients with malignant pleural effusion Source: Eur Respir J 2013; 41: 1409-1418 Year: 2013 Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011 Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung? Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Thoracoscopy in malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006 Prognostic value of metabolic imaging in non small cell lung cancers with neoplasic pleural effusion Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007 Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Cytotoxic T-lymphocyte status in peripheral blood and malignant pleural effusion in lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 63s Year: 2003 Epidemiology and clinical problems of orphant pleural adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006